ScinoPharm Taiwan, Ltd. (TPE:1789)
19.05
-0.15 (-0.78%)
May 9, 2025, 1:35 PM CST
ScinoPharm Taiwan Revenue
ScinoPharm Taiwan had revenue of 686.37M TWD in the quarter ending March 31, 2025, a decrease of -22.29%. This brings the company's revenue in the last twelve months to 3.21B, down -6.18% year-over-year. In the year 2024, ScinoPharm Taiwan had annual revenue of 3.41B with 6.91% growth.
Revenue (ttm)
3.21B
Revenue Growth
-6.18%
P/S Ratio
4.69
Revenue / Employee
5.94M
Employees
540
Market Cap
15.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.41B | 220.20M | 6.91% |
Dec 31, 2023 | 3.19B | -77.96M | -2.39% |
Dec 31, 2022 | 3.26B | 501.71M | 18.16% |
Dec 31, 2021 | 2.76B | -320.59M | -10.40% |
Dec 31, 2020 | 3.08B | 190.15M | 6.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |